Correlation Between Eliem Therapeutics and Pfizer

Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eliem Therapeutics and Pfizer Inc, you can compare the effects of market volatilities on Eliem Therapeutics and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Pfizer.

Diversification Opportunities for Eliem Therapeutics and Pfizer

0.01

Correlation Coefficient

Eliem Therapeutics  Pfizer

Significant diversification

The 3 months correlation between Eliem and Pfizer is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Pfizer go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Pfizer

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 7.69 times more return on investment than Pfizer. However, Eliem Therapeutics is 7.69 times more volatile than Pfizer Inc. It trades about 0.21 of its potential returns per unit of risk. Pfizer Inc is currently generating about 0.03 per unit of risk. If you would invest  267.00  in Eliem Therapeutics on February 9, 2024 and sell it today you would earn a total of  665.00  from holding Eliem Therapeutics or generate 249.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eliem Therapeutics  vs.  Pfizer Inc

Eliem Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Eliem Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eliem Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer Inc

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Eliem Therapeutics and Pfizer

The main advantage of trading using opposite Eliem Therapeutics and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Eliem Therapeutics and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.